HealthWatch Masthead
July 29, 2010 Issue No. 6
In This Issue
New blood thinning drugs post serious risks
Study begins on Cox procedure for neck pain
Studies document risks from common acid-suppressing meds
Related Sites


The World Chiropractic Alliance



The Chiropractic Journal





Join Us on Facebook
Follow Us on Twitter
Follow me on Twitter
Greetings!

Welcome to the latest edition of HealthWatch Newsletter. Our goal is to provide news that delivers the truth about health, wellness and total well-being. I hope you'll find this information useful, relevant and timely.

Best regards,

Terry A. Rondberg, DC
New blood thinning drugs post serious risks
CoumadinThree new oral blood-thinning drugs nearing approval by the Food and Drug Administration are touted as being more convenient than the standard drug, warfarin (brand name Coumadin) because they don't require monthly visits to adjust doses.
But the drugs also could be subject to dangerous interactions when taken alongside widely used prescription drugs, over-the-counter medicines including aspirin, and even herbal supplements such as St. John's Wort, according to a Loyola University Health System study. Read on...
Study begins on Cox procedure for neck pain
Palmer college of chiropracticMedical and chiropractic researchers are joining efforts to study the effects of Cox distraction manipulation for neck pain. The study is part of a four-year, $2.8 million National Institutes of Health grant awarded in 2008 to the Palmer Center for Chiropractic Research.
The study-scheduled to run through May 30, 2012-combines the efforts of medical doctors, chiropractors, biomechanists, and clinical researchers to document the effects of the Cox distraction chiropractic procedure on neck pain and develop sham and active treatment parameters for conducting clinical studies. Read on...
Studies document risks from common acid-suppressing meds
PillsProton pump inhibitors -- commonly prescribed medications that suppress acid in the stomach -- appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers, according to a series of reports in the May 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"A staggering 113.4 million prescriptions for proton pump inhibitors are filled each year, making this class of drugs, at $13.9 billion in sales, the third highest seller in the United States," wrote Mitchell H. Katz, MD, of the San Francisco Department of Public Health, in an editorial accompanying the reports. Read on...
About Us
The World Chiropractic Alliance
The WCA was founded in 1989 as a non-profit organization dedicated to protecting and strengthening chiropractic around the world. Serving as a "watchdog" and advocacy organization, we place our emphasis on education and political action. With members throughout the United States and in numerous foreign countries, the WCA is constantly being alerted to situations and events which might affect the practice of chiropractic.
The Chiropractic Journal
TCJ was started in 1986 in response to a widespread demand for a professionally edited newspaper which would present news and features of interest to all segments of the chiropractic profession.Today, the journal continues its founding mission to provide accurate, up-to-date and well-written reports of current events and issues; to offer an open forum for the opinions of all members of the profession; and to be an advocate for subluxation-based chiropractic and chiropractors, without sacrificing journalistic integrity.
Follow us on Twitter View our profile on LinkedIn Find us on Facebook